Key result
Lower BNP below ~391 pg/mL is linked to higher risk of intradialytic hypotension.
Why the study?
Intradialytic hypotension is a common hemodialysis complication associated with poor prognosis, prompting investigation of associated factors and the value of BNP in predicting it.
Does brain natriuretic peptide (BNP) level predict the occurrence of intradialytic hypotension in hemodialysis patients?
Cohort (n=123)
No
Does brain natriuretic peptide (BNP) level predict the occurrence of intradialytic hypotension in hemodialysis patients?
Odds Ratio: 0.999 (95% CI 0.997–1)
p-value: p=0.030
In hemodialysis patients with preserved ejection fraction, lower BNP levels are independently associated with an increased risk of intradialytic hypotension, suggesting its potential utility as a biomarker for volume depletion.
Background: Intradialytic hypotension (IDH) is a common complication of hemodialysis (HD) and is associated with an increased risk of poor prognosis. This study investigated the factors associated with IDH in HD patients and explored the value of brain natriuretic peptide (BNP) in predicting IDH. Methods: Participants were divided into two groups according to the occurrence of IDH. Differences in clinical data between the IDH and no-IDH groups were analyzed, and the influencing factors of IDH were analyzed using logistic regression. A receiver operating characteristic (ROC) curve was applied to identify the optimal critical value of BNP for the occurrence of IDH in HD patients. Results: A total of 123 HD patients were included, in which the percentage of IDH was 30.9%. In patients with IDH, the levels of BNP (224.4 vs. 464.7 pg/mL, p = 0.001), pre-HD systolic blood pressure (SBP) (153.0 vs. 162.0 mmHg, p = 0.002), pre-HD diastolic blood pressure (DBP) (75.7 vs. 84.1 mmHg, p = 0.001), post-HD SBP (134.2 vs. 154.2 mmHg, p < 0.001) and DBP (72.8 vs. 84.0 mmHg, p < 0.001) were significantly lower than those in the non-IDH group, and the level of ejection fraction (66.5 vs. 64.1%, p = 0.039) was significantly higher. Univariate analysis showed that BNP [odds ratio (OR) = 0.999, p = 0.015], pre-HD SBP (OR = 0.960, p = 0.001), and DBP (OR = 0.944, p = 0.001) were associated with IDH. Multivariate analysis revealed that lower BNP levels (OR = 0.999, p = 0.030), lower pre-HD DBP levels (OR = 0.928, p = 0.009), and higher body mass index (BMI) (OR = 1.133, p = 0.032) were independently correlated with IDH. BNP had a predictive value for the occurrence of IDH. Conclusions: BNP showed predictive value for IDH and may serve as a useful predictor of this complication. Its independent association with IDH supported its potential utility in clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2026) conducted a cohort in End-stage kidney disease on hemodialysis (n=123). Brain natriuretic peptide (BNP) levels vs. Higher BNP levels was evaluated on Occurrence of intradialytic hypotension (IDH) (OR 0.999, 95% CI 0.997-1.000, p=0.030). Lower brain natriuretic peptide levels were independently associated with the occurrence of intradialytic hypotension (OR 0.999, p=0.030), with an optimal predictive cut-off of 390.8 pg/mL.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: